| 核心作者 | 题目 | 杂志 | 影响因子 |
| 朱卫国 | SIRT7-mediated ATM deacetylation is essential for its deactivation and DNA damage repair | SCIENCE ADVANCES | 13.116 |
| 于力 | Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia | Nature Communications | 12.121 |
| 刘向宇 | CtIP is essential for early B cell proliferation and development in mice | Journal of Experimental Medicine | 11.743 |
| 朱卫国 | GLP-catalyzed H4K16me1 promotes 53BP1 recruitment to permit DNA damage repair and cell survival | NUCLEIC ACIDS RESEARCH | 11.501 |
| 靳广毅 | New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription | NUCLEIC ACIDS RESEARCH | 11.501 |
| 张素平 | Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody | PNAS | 9.412 |
| 吕德生 | Salinomycin exerts anti‐colorectal cancer activity by targeting the β‐catenin/T‐cell factor complex | British J of Pharmacology | 7.73 |
| 付利 | The immune landscape of esophageal cancer | Cancer Communications | 5.627 |
| 付利 | Therapeutic targeting of the crosstalk between cancer-associated fibroblasts and cancer stem cells | American Journal of Cancer Research | 5.177 |
| 于力 | Epigenetic modifier gene mutations-positive AML patients with intermediate-risk karyotypes benefit from decitabine with CAG regimen | International journal of cancer | 5.145 |
| 朱卫国 | A specific assay for JmjC domain-containing lysine demethylase and its application to inhibitor screening | Science China-Life sciences | 4.611 |
| 于力 | The RUNX1-ETO fusion protein trans-activates c-KIT expression by recruiting histone acetyltransferase P300 on its promoter | FEBS journal | 4.392 |
| 蔡志明 | A long way to the battlefront: CAR T cell therapy against solid cancers | Journal of Cancer | 3.565 |
| 吕德生 | Emetine exhibits anticancer activity in breast cancer cells as an antagonist of Wnt/β‑catenin signaling | ONCOLOGY REPORTS | 3.417 |
| 蔡志明 | Extracellular matrix protein 1 (ECM1) is associated with carcinogenesis potential of human bladder cancer | ONCOTARGETS AND THERAPY | 3.337 |
| 靳广毅 | Suppressive effects of sunitinib on a TLR activation-induced cytokine storm | European Journal of Pharmacology | 3.263 |
| 于力 | The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis | BMC cancer | 3.15 |
| 靳广毅 | Oxaliplatin-Based Platinum(IV) Prodrug Bearing Toll-like Receptor 7 Agonist for Enhanced Immunochemotherapy | ACS Omega | 2.87 |
用户登录
还没有账号？
立即注册